155 related articles for article (PubMed ID: 30681615)
21. Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia.
Benedek P; Jiao H; Duvefelt K; Skoog T; Linde M; Kiviluoma P; Kere J; Eriksson M; Angelin B
J Intern Med; 2021 Aug; 290(2):404-415. PubMed ID: 33955087
[TBL] [Abstract][Full Text] [Related]
22. Phenotype of definite familial hypercholesterolemia with negative genetic study in Argentina.
Corral P; Bañares V; Sáenz B; Zago V; Sarobe A; López G; Berg G; Schreier L
Arch Cardiol Mex; 2020; 90(2):130-136. PubMed ID: 32897268
[TBL] [Abstract][Full Text] [Related]
23. Low-density lipoprotein receptor gene mutation analysis and structure-function correlation in an Omani arab family with familial hypercholesterolemia.
Al-Rasadi K; Al-Waili K; Al-Zidi WA; Al-Abri AR; Al-Hinai AT; Al-Sabti HA; Al-Tobi S; Al-Zakwani I; Al-Zadjali F; Al-Hashmi K; Banerjee Y
Angiology; 2014 Nov; 65(10):911-8. PubMed ID: 24249837
[TBL] [Abstract][Full Text] [Related]
24. The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes.
Mariano C; Alves AC; Medeiros AM; Chora JR; Antunes M; Futema M; Humphries SE; Bourbon M
Clin Genet; 2020 Mar; 97(3):457-466. PubMed ID: 31893465
[TBL] [Abstract][Full Text] [Related]
25. [Familial hypercholesterolemia from the aspect of DNA analysis].
Horínek A; Sobra J; Ceska R; Paulasová P
Vnitr Lek; 1993 Oct; 39(10):946-50. PubMed ID: 7901941
[TBL] [Abstract][Full Text] [Related]
26. The island of Gran Canaria: A genetic isolate for familial hypercholesterolemia.
Sánchez-Hernández RM; Tugores A; Nóvoa FJ; Brito-Casillas Y; Expósito-Montesdeoca AB; Garay P; Bea AM; Riaño M; Pocovi M; Civeira F; Wägner AM; Boronat M
J Clin Lipidol; 2019; 13(4):618-626. PubMed ID: 31153816
[TBL] [Abstract][Full Text] [Related]
27. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.
Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H
Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288
[TBL] [Abstract][Full Text] [Related]
28. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.
Ohta N; Hori M; Takahashi A; Ogura M; Makino H; Tamanaha T; Fujiyama H; Miyamoto Y; Harada-Shiba M
J Clin Lipidol; 2016; 10(3):547-555.e5. PubMed ID: 27206942
[TBL] [Abstract][Full Text] [Related]
29. The study of familial hypercholesterolemia in Italy: A narrative review.
Bertolini S; Pisciotta L; Fasano T; Rabacchi C; Calandra S
Atheroscler Suppl; 2017 Oct; 29():1-10. PubMed ID: 28965614
[TBL] [Abstract][Full Text] [Related]
30. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
31. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
[TBL] [Abstract][Full Text] [Related]
32. Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients.
Hori M; Ohta N; Takahashi A; Masuda H; Isoda R; Yamamoto S; Son C; Ogura M; Hosoda K; Miyamoto Y; Harada-Shiba M
Atherosclerosis; 2019 Oct; 289():101-108. PubMed ID: 31491741
[TBL] [Abstract][Full Text] [Related]
33. Genetic Architecture of Familial Hypercholesterolaemia.
Sharifi M; Futema M; Nair D; Humphries SE
Curr Cardiol Rep; 2017 May; 19(5):44. PubMed ID: 28405938
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
[TBL] [Abstract][Full Text] [Related]
35. Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: integration and evolution of genetic diagnosis.
Di Taranto MD; D'Agostino MN; Fortunato G
Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):979-87. PubMed ID: 26165249
[TBL] [Abstract][Full Text] [Related]
36. ABCG5 and ABCG8 genetic variants in familial hypercholesterolemia.
Reeskamp LF; Volta A; Zuurbier L; Defesche JC; Hovingh GK; Grefhorst A
J Clin Lipidol; 2020; 14(2):207-217.e7. PubMed ID: 32088153
[TBL] [Abstract][Full Text] [Related]
37. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
[TBL] [Abstract][Full Text] [Related]
38. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
[TBL] [Abstract][Full Text] [Related]
39. Polygenic contribution for familial hypercholesterolemia (FH).
Medeiros AM; Bourbon M
Curr Opin Lipidol; 2021 Dec; 32(6):392-395. PubMed ID: 34751168
[TBL] [Abstract][Full Text] [Related]
40. Differences in allele frequencies of autosomal dominant hypercholesterolemia SNPs in the Malaysian population.
Alex L; Chahil JK; Lye SH; Bagali P; Ler LW
J Hum Genet; 2012 Jun; 57(6):358-62. PubMed ID: 22534770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
